Phase II study of thalidomide plus dexamethasone induction followed by tandem melphalan-based autotransplantation and thalidomide-plus-prednisone maintenance for untreated multiple myeloma: a southwest oncology group trial (S0204).
暂无分享,去创建一个
J. Crowley | B. Barlogie | A. Jakubowiak | V. Bolejack | J. Zonder | B. Durie | M. Hussein